Fundz

Shoreline Biome reported raising $1.09 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEMay 27, 2025$1.1M of $3M raised

Amount Raised

$1.09 Million

$1.09 Million sold, per SEC Form D (first sale May 15, 2025)

Round Type

Seed

FarmingtonBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Intus Bio that raised within 45 days of this round, from Fundz verified event records.

  • Lodestone Biomedical raised $75K (Seed) on June 29, 2025.
  • Biofrontera raised $11M on June 27, 2025.
  • Gallant raised $10M on June 27, 2025.
  • NewcelX raised $1M (Seed) on June 27, 2025.
  • Abvance Therapeutics raised an undisclosed amount (Seed) on June 27, 2025.
  • Juvena Therapeutics raised $30M on June 27, 2025.

Who to call at Intus Bio, and when

A new round usually means Intus Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Intus Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Intus Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Intus Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Intus Bio

Location

400 FARMINGTON AVENUE

Farmington, Connecticut, United States

About

Intus Bio was formerly known as Shoreline Biome. Intus Bio is using its proprietary high-resolution, high-throughput assay and analysis technology to identify bacteria and deliver answers about the microbiome, with unprecedented detail, accuracy and scale. The company is powering groundbreaking research, discovery and services with clients and partners across the global pharmaceutical, diagnostic, and testing industries; is active in health, agricultural, and environmental fields; and continues to develop new and innovative partnerships, technologies, and applications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Intus Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPaul D., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Intus Bio's next move

See what Strategic adds

Intus Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.